a1 Huashan Hospital, Fudan University, Shanghai, P.R. China
a2 Wellcome Trust Centre for Human Genetics, Oxford, UK
a3 Shanghai Mental Health Centre, Shanghai Jiao Tong University School of Medicine, Shanghai, P.R. China
a4 Tongji Hospital, Shanghai Tongji University, Shanghai, P.R. China
a5 Nanjing Brain Hospital, Nanjing, Jiangsu, P.R. China
a6 No. 4 Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, P.R. China
a7 Tianjin Anding Hospital, Hexi District, Tianjin, P.R. China
a8 Shandong Mental Health Centre, Jinan, Shandong, P.R. China
a9 No. 1 Hospital of Medical College of Xian Jiaotong University, Xi'an, Shaanxi, P.R. China
a10 No. 1 Hospital of Zhengzhou University, Zhengzhou, Henan, P.R. China
a11 No. 1 Mental Health Centre Affiliated Harbin Medical University, Nangang District, Harbin, Heilongjiang, P.R. China
a12 Mental Health Centre of West China Hospital of Sichuan University, Wu Hou District, Chengdu, Sichuan, P.R. China
a13 Beijing Anding Hospital, Capital Medical University, Xicheng District, Beijing, P.R. China
a14 Hebei Mental Health Centre, Baoding, Hebei, P.R. China
a15 Shengjing Hospital of China Medical University, Heping District Shenyang, Liaoning, P.R. China
a16 Shenzhen Kangning Hospital, Luo Hu, Shenzhen, Guangdong, P.R. China
a17 No. 3 Affiliated Hospital of Sun Yat-sen University, Tian He District, Guangzhou, Guangdong, P.R. China
a18 No. 1 Hospital of Shanxi Medical University, Taiyuan, Shanxi, P.R. China
a19 Mental Hospital of Jiangxi Province, Nanchang, Jiangxi, P.R. China
a20 The First Affiliated Hospital of Jinan University, Tian He District, Guangzhou, Guangdong, P.R. China
a21 Wuhan Mental Health Centre, Wuhan, P.R. China
a22 No. 3 Hospital of Heilongjiang Province, Beian, Heilongjiang, P.R. China
a23 Jilin Brain Hospital, Siping, Jilin, P.R. China
a24 The First Hospital of China Medical University, He Ping District, Shenyang, Liaoning, P.R. China
a25 Dalian No. 7 People's Hospital and Dalian Mental Health Centre, Gan Jing Zi District, Dalian, Liaoning, P.R. China
a26 The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, P.R. China
a27 Lanzhou University Second Hospital, Second Clinical Medical College of Lanzhou University, Lanzhou, Gansu Province, P.R. China
a28 Psychiatric Hospital of Henan Province, Xinxiang, Henan, P.R. China
a29 The Fourth Military Medical University affiliated Xijing Hospital, Xi'an, Shaanxi, P.R. China
a30 No. 4 People's Hospital of Liaocheng, Liaocheng, Shandong, P.R. China
a31 Guangzhou Brain Hospital/Guangzhou Psychiatric Hospital, Li Wan District, Guangzhou, Guangdong, P.R. China
a32 Clinical Trial Service Unit, Richard Doll Building, Oxford, UK
a33 Fuzhou Neuropsychiatric Hospital, Fuzhou City, Fujian, P.R. China
a34 Department of Psychiatry, Virginia Commonwealth University, Virginia Institute for Psychiatric and Behavioral Genetics, Richmond, VA, USA
Abstract
Background Studies in Western countries have repeatedly shown that women with a history of childhood sexual abuse (CSA) are at increased risk for developing major depression (MD). Would this relationship be found in China?
Method Three levels of CSA (non-genital, genital, and intercourse) were assessed by self-report in two groups of Han Chinese women: 1970 clinically ascertained with recurrent MD and 2597 matched controls. Diagnostic and other risk factor information was assessed at personal interview. Odds ratios (ORs) were calculated by logistic regression and regression coefficients by linear or Poisson regression.
Results Any form of CSA was significantly associated with recurrent MD [OR 3.26, 95% confidence interval (CI) 1.95–5.45]. This association strengthened with increasing CSA severity: non-genital (OR 2.47, 95% CI 1.17–5.23), genital (OR 2.77, 95% CI 1.32–5.83) and intercourse (OR 13.35, 95% CI 1.83–97.42). The association between any form of CSA and MD remained significant after accounting for parental history of depression, childhood emotional neglect (CEN), childhood physical abuse (CPA) and parent–child relationship. Among the depressed women, those with CSA had an earlier age of onset, longer depressive episodes and an increased risk for generalized anxiety disorder (GAD; OR 1.92, 95% CI 1.39–2.66) and dysthymia (OR 2.16, 95% CI 1.52–3.09).
Conclusions In Chinese women CSA is strongly associated with MD and this association increases with greater severity of CSA. Depressed women with CSA have an earlier age of onset, longer depressive episodes and increased co-morbidity with GAD and dysthymia. Although reporting biases cannot be ruled out, our results are consistent with the hypothesis that, as in Western countries, CSA substantially increases the risk for MD in China.
(Received March 02 2011)
(Revised July 06 2011)
(Accepted July 06 2011)
(Online publication August 11 2011)
Key Words:
Correspondence:
c1 Address for correspondence: J. Flint, M.D., Wellcome Trust Centre for Human Genetics, Oxford OX3 7BN, UK. (Email: jf@well.ox.ac.uk) [J. Flint]
c2 (Email shishenxun314@gmail.com) [S. Shi]